M&A / Deals

AbbVie climbs post-Allergan M&A peak with Apogee buy

Pharmaphorum

AbbVie has announced its biggest acquisition since the $63 billion merger with Allergan, buying Apogee and its 'mega-blockbuster' immunology pipeline.

Immunology & Inflammation

Read full story

pharminent June 22, 2026 (Last updated: June 22, 2026)

Pharmaphorum

AbbVie has announced its biggest acquisition since the $63 billion merger with Allergan, buying Apogee and its ‘mega-blockbuster’ immunology pipeline.

Immunology & Inflammation

Read full story

Related Stories

Lilly bets up to $800M for BioArctic’s brain delivery tech

Insilico and SK Bio forge $2.5bn AI neuroimmunity alliance

Sun Pharma to acquire Innovcare Lifesciences for $28.7m

You May Have Missed

AbbVie to Acquire Apogee Therapeutics for Nearly $11 Billion in Immunology Bet

AbbVie climbs post-Allergan M&A peak with Apogee buy

Lilly bets up to $800M for BioArctic’s brain delivery tech

Boehringer advances duo for aggressive cancers into phase 3